ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977